Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

INDUSTRY 240 OTHER 234 NIH 39 NETWORK 23 OTHER_GOV 6 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Nasopharyngeal Neoplasms 1 Locally Advanced Malignant Neoplasm 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

icotinib 2 Erlotinib Hydrochloride 2 pembrolizumab 1 camrelizumab 1 aumolertinib 1 apatinib 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Pemetrexed 1 Gemcitabine 1 Gefitinib 1 Drug Therapy 1 Cisplatin 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Carcinoma, Non-Small-Cell Lung × Cisplatin × Clear all

NCT04762459 2022-02-24

APEX

ChineseAMS

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡